1.
Emerg Infect Dis
; 30(3): 568-571, 2024 Mar.
Article
in English
| MEDLINE
| ID: mdl-38407158
ABSTRACT
Bedaquiline is currently a key drug for treating multidrug-resistant or rifampin-resistant tuberculosis. We report and discuss the unusual development of resistance to bedaquiline in a teenager in Namibia, despite an optimal background regimen and adherence. The report highlights the risk for bedaquiline resistance development and the need for rapid drug-resistance testing.